NAPANEE, ON, Jan. 7, 2019 /CNW/ - VIVO Cannabis Inc.
(TSX-V:VIVO, OTCQX: VVICF)("VIVO" or the "Company"),
a licensed cannabis producer offering premium medical and adult-use
products and services through its wholly-owned subsidiaries, ABcann
Medicinals Inc. ("ABcann") and Canna Farms Ltd. ("Canna
Farms"), today announce the appointment of Dr. Richa Love, MD, LMCC, CCFP, as the Company's
Chief Medical Officer.
Dr. Love serves as Medical Director at Harvest Medicine, VIVO's
wholly-owned network of specialty medical cannabis clinics that
offer education, care, advice and follow-up support to their
rapidly growing base of medical patients. She is also the founder
and Chief Executive Officer at CannU, an online cannabis education
and training resource for patients, consumers, retail workers and
health care professionals.
"Throughout her career, Dr. Love has provided thousands of
patients with cannabis assessments and has become an industry
leader in helping patients improve their lives with cannabis," said
Barry Fishman, Chief Executive
Officer at VIVO. "As Chief Medical Officer at VIVO, Dr. Love will
play a critical role in helping guide product development and
innovation, along with serving as a valuable resource for our
patients and team of healthcare and retail professionals. She makes
a great addition to our team of medical experts and further
strengthens our position as a leader in the medical cannabis
space."
Dr. Love supports an integrated approach to patient wellness and
is a passionate patient-advocate. She has spearheaded research
exploring the effects of medical cannabis for a variety of medical
conditions and hopes to use her findings to validate
cannabinoid-based therapies and the development of new delivery
mechanisms and formulations for specific medical conditions. Dr.
Love's broad expertise will shape VIVO's approach to patient
wellness and consumer education.
Dr. Love added, "In this role, I will support VIVO as the
Company continues to develop a best-in-class medical cannabis
offering, applying the rich insights I have gained through, my
research into cannabinoid-based therapies and through the thousands
of consultations I have had with patients seeking medical cannabis
treatment."
Dr. Love received her medical degree from the University of Calgary in 1998 with a speciality in
family practice from the University of
Alberta. She has been nominated for the Outstanding
Physician of the Year Award by the Alberta College of Family Physicians multiple
times, has sat on several medical boards, and has been involved in
physician governance, research, as well as advocacy and
teaching.
Dr. Love will represent VIVO at the 2019 Lift & Co. Expo in
Vancouver from January 11 to 13. Dr. Love will speak on two
panels; she will share her experiences from when she first entered
the medical cannabis space, explain the merits of certain cannabis
applications, and discuss the latest in medical cannabis research,
studies and treatments. To learn more about the Vancouver Lift
& Co. Expo, visit: https://liftexpo.ca/vancouver19/.
About VIVO Cannabis™
VIVO, based in Napanee,
Ontario, is recognized for trusted, high-quality products
and services. It holds production and sales licences from Health
Canada and operates world-class indoor cultivation facilities with
proprietary plant-growing technology. VIVO has a collection of
premium brands targeting unique customer segments, including Beacon
Medical™, FIRESIDE™, Canna Farms™ and Lumina™. In August 2018, VIVO acquired Canna Farms, a premium
cannabis company based in Hope, British
Columbia. Canna Farms was B.C.'s first Licensed Producer and
has several years of craft cultivation experience and expertise, as
well as a significant patient base and positive cash flow. The
Company is significantly expanding its production capacity and
pursuing partnership and product development opportunities
domestically, as well as in select international markets, including
Germany and Australia. VIVO also operates Harvest
Medicine, a patient-centric and highly scalable network of
specialty medical cannabis clinics as well as a free telemedicine
service. VIVO has a healthy balance sheet and is well-positioned to
accelerate their growth in Canada
and internationally.
Neither TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Disclaimer for Forward-Looking Statements
This news release contains forward-looking statements. These
forward-looking statements should not be read as guarantees of
future performance or results. Such statements involve known and
unknown risks, uncertainties and other factors that may cause
actual results, performance or achievements to be materially
different from those implied by such statements. A more complete
discussion of the risks and uncertainties facing the Company
appears in the Company's Annual Information Form for the year ended
December 31, 2017 and other
continuous disclosure filings, which are available on SEDAR at
www.sedar.com. Readers are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of the date
of this news release. The Company disclaims any intention or
obligation to update or revise any forward-looking statements as a
result of new information or future events, or for any other
reason, other than as required by applicable securities laws.
SOURCE VIVO Cannabis Inc.